In this study, we want to learn more about the safety and tolerability of a drug called NX-1607 in adult patients with advanced tumors. We want to see if this new drug may be able to slow the growth of your cancer.
COM_RESEARCHSTUDIES_DETAIL_HEADER_BASIC_CONTACT_4
North Carolina (Statewide)
Jared Weiss
LCCC - Clinical Trials
Clinical or Medical
Interventional
Cancer (Phase 1 Trials (all cancers))
22-2612